What's Going On With Clover Health Investments Stock?
What's Going On With Clover Health Investments Stock?
Clover also rose after Citigroup analyst Jason Cassorla maintained the company with a Neutral and raised the price target from $1 to $1.5 on Aug. 11.Clover Health Investments, Corp. (NASDAQ:CLOV) shares are trading higher Tuesday. A recent analyst price target change and a quarterly report were two of the catalysts moving the stock during the month.
三叶草健康投资公司 纳斯达克股票代码：CLOV）股价周二走高。最近的分析师目标股价变动和季度报告是本月推动该股走势的两个催化剂。
What To Know: Clover Health Investments reported second-quarter results earlier in the month. The company reported quarterly sales of $513.63 million which beat the analyst consensus estimate of $490.82 million, a 39.34% decrease over sales of $846.70 million the same period last year.
要知道什么： 三叶草健康投资在本月早些时候公布了第二季度业绩。该公司公布的季度销售额为5.1363亿美元，超过了分析师共识估计的4.9082亿美元，比去年同期的8.4670亿美元的销售额下降了39.34％。
The company also issued full-year 2023 EBITDA guidance in a range between losses of $70 million and $120 million, versus the previous estimate of losses between $125 million and $175 million.
该公司还发布了2023年全年息税折旧摊销前利润预期，亏损在7,000万美元至1.2亿美元之间，而之前估计的亏损在1.25亿美元至1.75亿美元之间。
Clover also rose after Citigroup analyst Jason Cassorla maintained the company with a Neutral and raised the price target from $1 to $1.5 on Aug. 11.
三叶草之后也升起了 花旗集团 分析师 杰森·卡索拉 维持该公司为中性，并于8月11日将目标股价从1美元上调至1.5美元。
The stock is up 43.85% over the past three months.
该股在过去三个月中上涨了43.85％。
Related Link: Why BigBear.ai Stock Popped Today
相关链接：为什么 BigBear.ai 股票今天暴涨
CLOV Price Action: Shares of CLOV were up 12.2% at $1.38 at the time of publication, according to Benzinga Pro.
CLOV 价格走势： 根据Benzinga Pro的数据，截至发布时，CLOV的股价上涨了12.2％，至1.38美元。
Image by Darko Stojanovic from Pixabay
图片由来自 Pixabay 的达尔科·斯托亚诺维奇拍摄
